✦ LIBER ✦

Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study

✍ Scribed by Marije W. Kroon; Bas S. Wind; Johan F. Beek; J.P. Wietze van der Veen; Ludmila Nieuweboer-Krobotová; Jan D. Bos; Albert Wolkerstorfer

Book ID: 116586733
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 307 KB
Volume: 64
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2010.01.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-ablative 1,550 nm fractional laser t

Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled split-face study

✍ Bas S. Wind; Marije W. Kroon; Arne A. Meesters; Johan F. Beek; J.P. Wietze van d 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract ## Background Melasma is a uichronic, often relapsing skin disorder, with poor long‐term results from all current therapies. ## Objective To assess efficacy and safety of non‐ablative 1,550 nm fractional laser therapy (FLT) as compared to the gold standard, triple topical therapy (TT

Comparison of fractional, nonablative, 1

Comparison of fractional, nonablative, 1550-nm laser and 595-nm pulsed dye laser for the treatment of facial erythema resulting from acne: A split-face, evaluator-blinded, randomized pilot study

✍ Park, Kui Young; Ko, Eun Jung; Seo, Seong Jun; Hong, Chang Kwun 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 840 KB

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB